Recommended Pages at pharmaceuticalonline.com
FDA Arthritis Advisory Committee Recommends Approval Of Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis
pharmaceuticalonline.com — “Pfizer Inc. (NYSE:PFE) announced today that the Arthritis Advisory Committee to the U.S. Food and Drug Administration (FDA) voted 8-2 to recommend” View full resource at pharmaceuticalonline.com
Most Recently Shared on May 12, 2012 at 7:07 am By:
FDA Arthritis Advisory Committee Recommends Approval Of Tofacitinib For Adult Patients With Moderately To Severe... http://t.co/soPAIfWQ
FDA Approves First Generic Lexapro To Treat Depression And
pharmaceuticalonline.com — “FDA Approves First Generic Lexapro To Treat Depression And Anxiety Disorder - The U.S. Food and Drug Administration” View full resource at pharmaceuticalonline.com
Most Recently Shared on March 15, 2012 at 6:41 am By:
Depression Wisdom Active Health Library and OW Health
FDA Approves First Generic Lexapro To Treat Depression And Anxiety Disorder: The U.S. Food and Drug Administrati... http://t.co/P0w5h2YO
Synergy Pharmaceuticals Raises $5.64 Million in Financing
pharmaceuticalonline.com — “Synergy Pharmaceuticals Raises $5.64 Million in Financing - Synergy Pharmaceuticals, Inc” View full resource at pharmaceuticalonline.com
Most Recently Shared on November 17, 2011 at 7:50 am By:
Synergy Pharmaceuticals Raises $5.64M In Financing: Synergy Pharmaceuticals, Inc., a developer of new drugs to t... http://t.co/deZnXiva
Roche’s Tarceva Receives European Approval For First-Line Use In
pharmaceuticalonline.com — “Roche’s Tarceva Receives European Approval For First-Line Use In A Genetically Distinct Type Of Lung Cancer” View full resource at pharmaceuticalonline.com
Most Recently Shared on September 6, 2011 at 7:59 pm By:
Roche's Tarceva Receives European Approval For First-Line Use In A Genetically Distinct Type Of Lung Cancer: Per... http://t.co/YumJGhI
Amylin And Takeda Discontinue Development Of
pharmaceuticalonline.com — “Amylin And Takeda Discontinue Development Of Pramlintide/Metreleptin Combination Treatment For Obesity Following Commercial Reassessment Of The Program - Amylin Pharmaceuticals” View full resource at pharmaceuticalonline.com
Most Recently Shared on August 8, 2011 at 5:22 pm By:
Amylin And Takeda Discontinue Development Of Pramlintide/Metreleptin Combination Treatment For Obesity Following... http://bit.ly/qIIhxi
Merck: Regulatory Update On Cladribine Tablets
pharmaceuticalonline.com — “Merck: Regulatory Update On Cladribine Tablets - Merck KGaA” View full resource at pharmaceuticalonline.com
Most Recently Shared on June 23, 2011 at 8:31 am By:
Merck: Regulatory Update On Cladribine Tablets: Merck KGaA announced recently that following feedback from regul... http://bit.ly/jGhI2l
FDA Update: May 2011
pharmaceuticalonline.com — “FDA Update: May 2011” View full resource at pharmaceuticalonline.com
Most Recently Shared on May 9, 2011 at 8:10 pm By:
FDA Update: May 2011: Patients with Type 2 diabetes now have another treatment option. The FDA approved Tradjent... http://bit.ly/mgX6aE
Avanir Pharmaceuticals Announces Filing Of IND For AVP-923 For
pharmaceuticalonline.com — “Avanir Pharmaceuticals Announces Filing Of IND For AVP-923 For The Treatment Of Central Neuropathic Pain In Patients With Multiple Sclerosis - Avanir Pharmaceuticals, Inc.” View full resource at pharmaceuticalonline.com
Most Recently Shared on April 5, 2011 at 3:23 pm By:
Urology & Nephrology OW Health
Avanir Pharmaceuticals Announces Filing Of IND For AVP-923 For The Treatment Of Central Neuropathic Pain In Pati... http://bit.ly/hHd89o
Portola Pharmaceuticals To Regain Global Rights For
pharmaceuticalonline.com — “Portola Pharmaceuticals To Regain Global Rights For Investigational Medicine Betrixaban From Merck” View full resource at pharmaceuticalonline.com
Most Recently Shared on March 26, 2011 at 12:54 pm By:
Portola Pharmaceuticals To Regain Global Rights For Investigational Medicine Betrixaban From Merck: Portola Phar... http://bit.ly/e3OIlx
Using Amphetamines May Increase Risk Of Parkinson's Disease
pharmaceuticalonline.com — “Using Amphetamines May Increase Risk Of Parkinson's Disease” View full resource at pharmaceuticalonline.com
Most Recently Shared on February 25, 2011 at 1:48 am By:
Using Amphetamines May Increase Risk Of Parkinson's Disease: New research shows people who have used amphetamine... http://bit.ly/gFM2fF
Lilly, Bristol-Myers Squibb Stop Enrollment In One Of Two Phase
pharmaceuticalonline.com — “Lilly, Bristol-Myers Squibb Stop Enrollment In One Of Two Phase III Lung Cancer Trials Of Necitumumab - Eli Lilly and Company” View full resource at pharmaceuticalonline.com
Most Recently Shared on February 8, 2011 at 6:41 am By:
Lilly, Bristol-Myers Squibb Stop Enrollment In One Of Two Phase III Lung Cancer Trials Of Necitumumab: Eli Lilly... http://bit.ly/ftreJQ
FDA Limits Acetaminophen In Prescription Combination Products;
pharmaceuticalonline.com — “FDA Limits Acetaminophen In Prescription Combination Products; Requires Liver Toxicity Warnings” View full resource at pharmaceuticalonline.com
Most Recently Shared on January 14, 2011 at 2:17 am By:
FDA Limits Acetaminophen In Prescription Combination Products; Requires Liver Toxicity Warnings: The U.S. Food a... http://bit.ly/eV3UIb
NovaBay Pharmaceuticals Reports Activity Of Aganocide NVC-422
pharmaceuticalonline.com — “NovaBay Pharmaceuticals Reports Activity Of Aganocide NVC-422 Against Deadly --'Superbug--™ Producing NDM-1 (New Delhi Metallo-Beta-Lactamase-1) - NovaBay Pharmaceuticals, Inc.” View full resource at pharmaceuticalonline.com
Most Recently Shared on January 11, 2011 at 11:24 am By:
Ear, Nose, and Throat OW Health
NovaBay Pharmaceuticals Reports Activity Of Aganocide NVC-422 Against Deadly 'Superbug' Producing NDM-1 (New Del... http://bit.ly/gGQBmC
Lexicon Announces Top-Line Phase 2a Data For LX2931 In Patients
pharmaceuticalonline.com — “Lexicon Announces Top-Line Phase 2a Data For LX2931 In Patients With Rheumatoid Arthritis - Lexicon Pharmaceuticals, Inc.” View full resource at pharmaceuticalonline.com
Most Recently Shared on December 15, 2010 at 12:06 pm By:
Lexicon Announces Top-Line Phase 2a Data For LX2931 In Patients With Rheumatoid Arthritis: Lexicon Pharmaceutica... http://bit.ly/fz2JaY
IDRI Develops Novel Tuberculosis Vaccine, New Study In Science R
pharmaceuticalonline.com — “IDRI Develops Novel Tuberculosis Vaccine, New Study In Science Reports - The Infectious Disease Research Institute” View full resource at pharmaceuticalonline.com
Most Recently Shared on October 19, 2010 at 9:59 am By:
IDRI Develops Novel Tuberculosis Vaccine, New Study In Science Reports: The Infectious Disease Research Inst... http://tinyurl.com/264j9ls
